RetourWHO policy guidance on TB diagnostics and laboratory strengthening
WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis – rapid diagnostics for tuberculosis detection, third edition. Geneva: World Health Organization; In press.WHO End TB Strategy: global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization; 2015 (https://www.who.int/publications/i/item/WHO-HTM-TB-2015.19).
Framework of indicators and targets for laboratory strengthening under the End TB Strategy (WHO/HTM/TB/2016.18). Geneva: World Health Organization; 2016 (https://www.who.int/publications/i/item/9789241511438).
Considerations for adoption and use of multi-disease testing devices in integrated laboratory networks (WHO/HTM/TB/2017.06). Geneva: World Health Organization; 2017 (https://www.who.int/publications/i/item/WHO-HTM-TB-2017.06).
WHO policy guidance on TB screening and treatment
WHO consolidated guidelines on tuberculosis. Module 2 – Screening: systematic screening for tuberculosis disease. Geneva: World Health Organization; 2021 (https://www.who.int/publications/i/item/9789240022676).
WHO consolidated guidelines on tuberculosis. Module 4 – Treatment: drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240063129).
WHO consolidated guidelines on tuberculosis. Module 4 – Treatment: drug-susceptible tuberculosis treatment. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240048126).
Guidance on implementation of diagnostic tests
Practical manual on tuberculosis laboratory strengthening, 2022 update. Geneva: World Health Organization; 2023 (https://www.who.int/publications/i/item/9789240061507).
The use of next-generation sequencing for the surveillance of drug-resistant tuberculosis: an implementation manual. Geneva: World Health Organization; 2023 (https://www.who.int/publications/i/item/9789240078079).
Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, 2nd edition. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/374061).
Manual for selection of molecular WHO recommended rapid diagnostic tests for detection of tuberculosis and drug-resistant tuberculosis. Geneva: Global Laboratory Initiative; 2022 (https://www.stoptb.org/manual-selection-of-molecular-who-recommended-rapid-diagnostic-tests-detection-of-tuberculosis-and-0).
GLI specimen referral toolkit. Geneva: Global Laboratory Initiative; 2017 (https://www.stoptb.org/gli-guidance-and-tools/gli-specimen-referral-toolkit).
GLI practical guide to implementation of Truenat™ Tests for the detection of TB and Rifampicin resistance. Geneva: Global Laboratory Initiative; 2021 (https://www.stoptb.org/gli-guidance-and-tools/practical-guide-to-implementation-of-truenat-tests).
GLI practical implementation of lateral flow urine lipoarabinomannan assay (LF-LAM) for detection of active tuberculosis in people living with HIV. Global Laboratory Initiative; 2021 (https://www.stoptb.org/gli-guidance-and-tools/practical-implementation-of-lf-lam-detection-of-active-tb-people-living-with).
GLI practical guide to implementing a quality assurance system for Xpert MTB/RIF testing. Global Laboratory Initiative; 2021 (https://www.stoptb.org/working-group-pages/practicalguide-to-implementing-quality-assurance-system-xpert-mtbrif-testing)
Practical considerations for implementation of the loop-mediated isothermal amplification (TB-LAMP) test. Global Laboratory Initiative; 2021 (https://www.stoptb.org/file/10485/download).